187 related articles for article (PubMed ID: 20351234)
21. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice.
Wang YX; Martin-McNulty B; Freay AD; Sukovich DA; Halks-Miller M; Li WW; Vergona R; Sullivan ME; Morser J; Dole WP; Deng GG
Am J Pathol; 2001 Oct; 159(4):1455-64. PubMed ID: 11583973
[TBL] [Abstract][Full Text] [Related]
23. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
24. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
25. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
26. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
27. Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion.
Fleetwood AJ; Achuthan A; Schultz H; Nansen A; Almholt K; Usher P; Hamilton JA
J Immunol; 2014 Apr; 192(8):3540-7. PubMed ID: 24616477
[TBL] [Abstract][Full Text] [Related]
28. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.
Van der Donckt C; Van Herck JL; Schrijvers DM; Vanhoutte G; Verhoye M; Blockx I; Van Der Linden A; Bauters D; Lijnen HR; Sluimer JC; Roth L; Van Hove CE; Fransen P; Knaapen MW; Hervent AS; De Keulenaer GW; Bult H; Martinet W; Herman AG; De Meyer GR
Eur Heart J; 2015 May; 36(17):1049-58. PubMed ID: 24553721
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator expression in human atherosclerotic lesions.
Lupu F; Heim DA; Bachmann F; Hurni M; Kakkar VV; Kruithof EK
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1444-55. PubMed ID: 7670960
[TBL] [Abstract][Full Text] [Related]
30. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation.
Silence J; Lupu F; Collen D; Lijnen HR
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1440-5. PubMed ID: 11557669
[TBL] [Abstract][Full Text] [Related]
31. Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages.
Meznarich J; Malchodi L; Helterline D; Ramsey SA; Bertko K; Plummer T; Plawman A; Gold E; Stempien-Otero A
PLoS One; 2013; 8(3):e57837. PubMed ID: 23536772
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
33. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice.
Williams H; Johnson JL; Carson KG; Jackson CL
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):788-92. PubMed ID: 12006391
[TBL] [Abstract][Full Text] [Related]
35. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
36. c-Myc is essential for urokinase plasminogen activator expression on hypoxia-induced vascular smooth muscle cells.
Hou Y; Okamoto C; Okada K; Kawao N; Kawata S; Ueshima S; Matsuo O
Cardiovasc Res; 2007 Jul; 75(1):186-94. PubMed ID: 17382917
[TBL] [Abstract][Full Text] [Related]
37. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
Shah PK; Falk E; Badimon JJ; Fernandez-Ortiz A; Mailhac A; Villareal-Levy G; Fallon JT; Regnstrom J; Fuster V
Circulation; 1995 Sep; 92(6):1565-9. PubMed ID: 7664441
[TBL] [Abstract][Full Text] [Related]
38. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
39. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice.
Ni M; Wang Y; Zhang M; Zhang PF; Ding SF; Liu CX; Liu XL; Zhao YX; Zhang Y
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1598-606. PubMed ID: 19286965
[TBL] [Abstract][Full Text] [Related]
40. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe.
Sato K; Nakano K; Katsuki S; Matoba T; Osada K; Sawamura T; Sunagawa K; Egashira K
J Atheroscler Thromb; 2012; 19(11):986-98. PubMed ID: 22785139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
